Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ahodgins
    Junior Member
    • Jan 2010
    • 4

    #1

    maxing out multiplexing in mRNA seq?

    Hi all,

    We are designing an experiment in which we are interested in measuring 100+ transcriptomes using Illumina mRNA sequencing. I wonder whether anyone who is currently doing multiplexing for transcriptome analysis has any experience to share about relative depth of coverage at different levels of multiplexing. What would be the maximum number of transcriptomic samples you would be comfortable combining in a single lane with the GAII? (We work with yeast.)

    Many thanks,

    Andrea
  • JakobHedegaard
    Member
    • Mar 2008
    • 62

    #2
    Hi Andrea,

    It depends on how many sequences you will need per sample. If you are happy with 5 M sequences per sample you can combine 7-8 samples per lane (if working on a GAIIx with an expected 35-40 M sequences/lane).

    You could also combine more samples (e.g. 20-plex) and then repeat on several lanes (and in different flowcells) to gain enough sequences. This aproach migth be usefull if you would like to account for the minor differences between flowcells/runs.

    Cheers,
    Jakob

    Comment

    • epistatic
      Senior Member
      • Mar 2009
      • 129

      #3
      Hi Andrea,

      I have done about 32 RNA-Seq libraries for S. cerevisiae. All of the GAIIx data we generate and I have had generated off-site are more in the 20-30M range, ~25M read average per lane. For all of these, I have done 4-plex to balance the bases in the index and have enough coverage for things that pop up like unmapped reads, rRNA contamination, less even coverage from mixing libraries, etc. This will change when we get our HiSeq up and running, I have been told to expect ~120M+ reads per lane and I will be able to do more samples per lane at a lower run cost. I am also moving towards strand-specific and DSN normalized, which may need more reads.

      I really like the NuGEN NGS library prep and multiplexing kit. The kit supports 8-plex, but the real benefit is that the index is in the first 4 bp of the read (5' most end). The Illumina indexing needs a second read for the index, either adding cost or reducing your first read. I made an equimolar mix of the four libraries together (BC1 - BC4, BC5 - BC8) and then I sequence in a standard SR-36 run.
      Last edited by epistatic; 01-08-2011, 11:10 AM.

      Comment

      • epistatic
        Senior Member
        • Mar 2009
        • 129

        #4
        Results of 4-plex on two GAIIx lanes

        Multiplexed yeast mRNA-Seq, Illumina GAIIx 10/2010

        Read Counts
        Index, Lane 1, Lane 2, BC#
        ACCC, 5264469, 28367, BC1
        CGTA, 10523020, 77495, BC2
        GAGT, 6176660, 60123, BC3
        TTAG, 7077502, 199002, BC4
        AGGG, 175973, 8185099, BC5
        CCAT, 18504, 7832521, BC6
        GTCA, 26668, 7003926, BC7
        TATC, 7576, 4831595, BC8

        % of lane
        Index, Lane 1, Lane 2, BC#
        ACCC, 16.69%, 0.09%, BC1
        CGTA, 33.36%, 0.25%, BC2
        GAGT, 19.58%, 0.19%, BC3
        TTAG, 22.44%, 0.64%, BC4
        AGGG, 0.56%, 26.52%, BC5
        CCAT, 0.06%, 25.37%, BC6
        GTCA, 0.08%, 22.69%, BC7
        TATC, 0.02%, 15.65%, BC8

        Comment

        • ahodgins
          Junior Member
          • Jan 2010
          • 4

          #5
          Many thanks all!! This was very helpful.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          22 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          39 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          45 views
          0 reactions
          Last Post SEQadmin2  
          Working...